Chemours (NYSE:CC – Get Free Report) issued its quarterly earnings data on Tuesday. The specialty chemicals company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.07, Briefing.com reports. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. The company had revenue […]
Chemours (NYSE:CC – Get Free Report) issued its earnings results on Tuesday. The specialty chemicals company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.07, Briefing.com reports. The business had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.35 billion. Chemours had a positive […]
Chemours (NYSE:CC – Get Free Report) announced its quarterly earnings data on Tuesday. The specialty chemicals company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.07, Briefing.com reports. The company had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.35 billion. Chemours had a […]
Chemours (NYSE:CC – Get Free Report) will release its earnings data after the market closes on Tuesday, April 30th. Analysts expect Chemours to post earnings of $0.25 per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link. Chemours (NYSE:CC – Get Free Report) last […]
Bryn Mawr Capital Management LLC boosted its holdings in The Chemours Company (NYSE:CC – Free Report) by 135.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 27,205 shares of the specialty chemicals company’s stock after buying an additional 15,662 shares during the period. Bryn Mawr Capital Management […]